Literature DB >> 15514580

Lymphogranuloma venereum among men who have sex with men--Netherlands, 2003-2004.

.   

Abstract

Lymphogranuloma venereum (LGV) is a systemic, sexually transmitted disease (STD) caused by a variety of the bacterium Chlamydia trachomatis that rarely occurs in the United States and other industrialized countries; the prevalence of LGV is greatest in Africa, Southeast Asia, Central and South America, and Caribbean countries. However, in the Netherlands, which typically has fewer than five cases a year, as of September 2004, a total of 92 cases of LGV had been confirmed during the preceding 17 months among men who have sex with men (MSM). The first 13 cases, diagnosed during April-November 2003, were reported by local health authorities in Rotterdam in December 2003. An alert was sent to the Early Warning and Reporting System of the European Union and to the European Surveillance of Sexually Transmitted Infections Network (ESSTI). In April 2004, a report was made to CDC, and state and local health departments were alerted. Of the 92 cases confirmed in the Netherlands, 30 occurred during 2003 and 62 during 2004. This report describes the ongoing investigation of the LGV outbreak. Health-care providers should be vigilant for LGV, especially among MSM exposed to persons from Europe, and prepared to diagnose the disease and provide appropriate treatment to patients and their exposed sex partners.

Entities:  

Mesh:

Year:  2004        PMID: 15514580

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  15 in total

1.  Lymphogranuloma venereum in the differential diagnosis of proctitis.

Authors:  Erica Weir
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

2.  Lymphogranuloma venereum.

Authors:  A Herring; J Richens
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

Review 3.  Dermatologic care for lesbian, gay, bisexual, and transgender persons: Epidemiology, screening, and disease prevention.

Authors:  Howa Yeung; Kevin M Luk; Suephy C Chen; Brian A Ginsberg; Kenneth A Katz
Journal:  J Am Acad Dermatol       Date:  2019-03       Impact factor: 11.527

Review 4.  Comprehensive clinical care for men who have sex with men: an integrated approach.

Authors:  Kenneth H Mayer; Linda-Gail Bekker; Ron Stall; Andrew E Grulich; Grant Colfax; Javier R Lama
Journal:  Lancet       Date:  2012-07-20       Impact factor: 79.321

5.  Laboratory Processes for Confirmation of Lymphogranuloma Venereum Infection During a 2015 Investigation of a Cluster of Cases in the United States.

Authors:  Ellen N Kersh; Allan Pillay; Alex de Voux; Cheng Chen
Journal:  Sex Transm Dis       Date:  2017-11       Impact factor: 2.830

Review 6.  [Lymphogranuloma venereum. Two cases from Dresden].

Authors:  P Spornraft-Ragaller; C Lück; E Straube; M Meurer
Journal:  Hautarzt       Date:  2006-12       Impact factor: 0.751

7.  Comparison of Chlamydia trachomatis serovar L2 growth in polarized genital epithelial cells grown in three-dimensional culture with non-polarized cells.

Authors:  Sophie Dessus-Babus; Cheryl G Moore; Judy D Whittimore; Priscilla B Wyrick
Journal:  Microbes Infect       Date:  2008-02-21       Impact factor: 2.700

8.  Sexually Transmitted Diseases in Travelers.

Authors:  Noreen A Hynes
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.663

9.  Hypervirulent Chlamydia trachomatis clinical strain is a recombinant between lymphogranuloma venereum (L(2)) and D lineages.

Authors:  Naraporn Somboonna; Raymond Wan; David M Ojcius; Matthew A Pettengill; Sandeep J Joseph; Alexander Chang; Ray Hsu; Timothy D Read; Deborah Dean
Journal:  MBio       Date:  2011-05-03       Impact factor: 7.867

10.  Emerging issues in management of sexually transmitted diseases in HIV infection.

Authors:  Christopher S Hall; Jeanne D Marrazzo
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.